Capital International Investors 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 11:19 am Sale |
2022-02-14 | 13G | Vir Biotechnology, Inc. VIR |
Capital International Investors | 5,634,019 4.300% |
-5,806,552 (-50.75%) |
Filing |
| 2021-02-16 2:24 pm Unchanged |
2021-02-16 | 13G | Vir Biotechnology, Inc. VIR |
Capital International Investors | 11,440,571 9.000% |
0 (Unchanged) |
Filing |
| 2021-02-16 1:57 pm Purchase |
2021-02-16 | 13G | Vir Biotechnology, Inc. VIR |
Capital International Investors | 11,440,571 9.000% |
11,440,571 (New Position) |
Filing |